Ronald Schneider, B.S.Pharm., M.H.A.; Jonathan Bagby, R.N., M.B.A., M.S.N.; Russ Carlson, R.N., B.S.N., M.H.A. Am J Health Syst Pharm. 2008;65(23):2216-2219. In 1994 ...
Implementing the Medicare $2 drug list model would have reduced out-of-pocket spending by 63% for Part D beneficiaries in 2021. The model caps cost-sharing at $2 for a 30-day supply of 101 generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results